Trials / Completed
CompletedNCT03744806
Blood-aqueous Barrier Integrity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular AMD
Blood-aqueous Barrier Integrity in Eyes Undergoing Intravitreal Bevacizumab Therapy to Treat Neovascular Age-related Macular Degeneration
- Status
- Completed
- Phase
- —
- Study type
- Observational
- Enrollment
- 48 (actual)
- Sponsor
- Medical University of Lublin · Academic / Other
- Sex
- All
- Age
- —
- Healthy volunteers
- —
Summary
The aim of this study is to evaluate the effect of repeated intravitreal bevacizumab injections on blood-aqueous barrier permeability in eyes with neovascular age-related macular degeneration (AMD).
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Bevacizumab Injection |
Timeline
- Start date
- 2015-01-01
- Primary completion
- 2015-09-01
- Completion
- 2018-08-01
- First posted
- 2018-11-16
- Last updated
- 2018-11-16
Source: ClinicalTrials.gov record NCT03744806. Inclusion in this directory is not an endorsement.